Publications by Dr Jolanta Weaver - ePrints

Browsing publications by Dr Jolanta Weaver.

Newcastle Authors	Title	Year
Dr Sherin Bakhashab Rosie Barber Josie O'Neill Dr Catherine Arden Dr Jolanta Weaver et al.	Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression	2024
Dr Sherin Bakhashab Josie O'Neill Rosie Barber Dr Catherine Arden Dr Jolanta Weaver et al.	Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy	2024
Jason Phowira Nicholas Vennart Dr Jolanta Weaver	Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up	2022
Jason Phowira Dr Sherin Bakhashab Anuradha Doddaballapur Dr Jolanta Weaver	Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function	2022
Nicholas Vennart Dr Jolanta Weaver Dr Salman Razvi	The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease	2022
Jason Phowira Dr Fahad Ahmed Dr Sherin Bakhashab Dr Jolanta Weaver	Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study	2022
Dr Sherin Bakhashab Jevi Latief Dr Jolanta Weaver	MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)	2021
Alice Tamara Jevi Latief Dr Jolanta Weaver	Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health	2021
Sabby Ray Alice Tamara Jevi Latief Dr Sherin Bakhashab Dr Jolanta Weaver et al.	The role of miR-342 in vascular health. Study in subclinical cardiovascular disease in mononuclear cells, plasma, inflammatory cytokines and PANX2	2020
Professor Philip Preshaw Dr John Taylor Dr Katrin Jaedicke Dr Susan Bissett Paiboon Jitprasertwong et al.	Treatment of periodontitis reduces systemic inflammation in type 2 diabetes	2020
Dr Arjola Bano Dr Earn Gan Dr Jolanta Weaver Dr Salman Razvi	Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease	2018
Dr Fahad Ahmed Dr Sherin Bakhashab INDA Bastaman Dr Rachel Crossland Dr Michael Glanville et al.	Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study	2018
Dr Sherin Bakhashab Dr Fahad Ahmed Dr Michael Glanville Dr Jolanta Weaver	Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1/2 and their signaling under hyperglycemia-hypoxia	2018
Dr Andy Colman Dr Jolanta Weaver	Use of Quick Response (QR) coded bracelets and cards for the improvement of cortisol deficiency/Addison's disease management: an audit of quality of care of the management of steroid deficiency in acute illness	2018
Dr Fahad Ahmed Rachel Rider Dr Michael Glanville Dr Salman Razvi Dr Jolanta Weaver et al.	Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study	2016
Sherin Bakhashab Dr Fahad Ahmed Dr Jolanta Weaver	Metformin improves the angiogenic potential of human CD34⁺cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction	2016
Dr Sherin Bakhashab Dr Jolanta Weaver	Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma	2016
Dr Sviatlana Zhyzhneuskaya Dr Jolanta Weaver Dr Salman Razvi	The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds	2016
Dr Daniel West Professor Mark Walker Professor James Shaw Dr Fahad Ahmed Stephanie Wijaya et al.	Inflammation and the acute endothelial progenitor cell response to submaximal running exercise in males with and without Type 1 diabetes	2015
Dr Asgar Madathil Dr Kieren Hollingsworth Professor Andrew Blamire Dr Salman Razvi Emerita Professor Julia Newton et al.	Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study	2015
Dr Anna Mitchell Katie MacArthur Dr Jolanta Weaver Dr Bijayeswar Vaidya Dr Rebecca Darlay et al.	Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus	2015
Professor Mark Walker Dr Fahad Ahmed Stephanie Wijaya Professor James Shaw Dr Jolanta Weaver et al.	The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study	2015
Dr Fahad Ahmed Dr Jolanta Weaver	Metformin improves endothelial progenitor cell number in Type 1 diabetes: MERIT study preliminary report	2014
Sherin Bakhashab Dr Fahad Ahmed Dr Jolanta Weaver	Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells	2014
Jedrzej Hoffmann Dr Karel Fiser Dr Jolanta Weaver Ian Dimmick Monika Loeher et al.	High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction	2012
Dr Salman Razvi Dr Jolanta Weaver Dr Tim Butler Professor Simon Pearce	Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality	2012
Dr Shaikh Abdul Shakoor Dr Ali Aldibbiat Lorna Ingoe Dr Susan Campbell Dr Latika Sibal et al.	Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy	2010
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce	Subclinical thyroid disorders: significance and clinical impact	2010
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce	The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort	2010
Dr Latika Sibal Dr Ali Aldibbiat Dr Sharad Agarwal Crispian Oates Dr Salman Razvi et al.	Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria	2009
Dr Jolanta Weaver	Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study)	2009
Dr Akheel Syed Dr Christina Halpin Professor Julie Irving Professor Nigel Unwin Professor Martin White et al.	A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men	2008
Dr Jolanta Weaver	Classical endocrine diseases causing obesity	2008
Dr Jolanta Weaver	Classical endocrine diseases causing obesity	2008
Dr Salman Razvi Dr Jolanta Weaver	Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ	2008
Dr Akheel Syed Dr Chris Redfern Dr Jolanta Weaver	In vivo and in vitro glucocorticoid sensitivity in obese people with cushingoid appearance	2008
Hannah Fraser Professor Philip Preshaw Professor Roy Taylor Dr Jolanta Weaver Dr Rebecca Wassall et al.	Oral Hygiene and Periodontal Health in Type 1 Diabetes Patients	2008
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce	The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis	2008
Dr Latika Sibal Dr Ali Aldibbiat Crispian Oates Dr Jolanta Weaver Professor James Shaw et al.	The influence of the presence of retinopathy on the circulating endothelial progenitor cell counts, endothelial function and carotid intima-media thickness in type I diabetes	2008
Dr Jolanta Weaver	Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease	2007
Dr Latika Sibal Dr Ali Aldibbiat Dr Jolanta Weaver Dr Salman Razvi Crispian Oates et al.	Endothelial dysfunction and circulating endothelial progenitor cells in young people with type 1 diabetes	2007
Dr Latika Sibal Dr Ali Aldibbiat Dr Sharad Agarwal Dr Jolanta Weaver Dr Salman Razvi et al.	Endothelial dysfunction, carotid intima media thickness and circulating endothelial progenitor cells in young people with Type 1 diabetes	2007
Dr Jolanta Weaver	RCT of continuous glucose monitoring devices on HbA(1C) - The MITRE study	2007
Dr Salman Razvi Lorna Ingoe Crispian Oates Dr Jolanta Weaver	The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial	2007
Dr Jolanta Weaver	Use and acceptability of two minimally invasive continuous blood glucose monitors	2007
Dr Akheel Syed Professor Julie Irving Dr Chris Redfern Dr Andrew Hall Professor Nigel Unwin et al.	Association of glucocorticoid receptor polymorphism A3669G in exon 9β with reduced central adiposity in women	2006
Dr Jolanta Weaver	Borderline thyroid function tests: so easy to look at, so hard to define	2006
Dr Salman Razvi Dr Jolanta Weaver	Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: The ThyTSQ	2006
Dr Jolanta Weaver Dr Salman Razvi	Dose of anti-thyroid drugs can effect remission in grave's disease	2005
Dr Akheel Syed Dr Jolanta Weaver	Glucocorticoid sensitivity: The hypothalamic-pituitary-adrenal-tissue axis	2005
Dr Salman Razvi Lorna Ingoe Dr Jolanta Weaver	Health status in patients with sub-clinical hypothyroidism	2005
Dr Salman Razvi Dr Jolanta Weaver	Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review	2005
Dr Jolanta Weaver	Obesity, cytokines and the search for beauty	2005
Dr Jolanta Weaver Dr Salman Razvi	The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake [2] (multiple letters)	2005
Dr Akheel Syed Dr Chris Redfern Dr Jolanta Weaver	Aldosterone revisited	2004
Dr Salman Razvi Dr Jolanta Weaver	Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism	2004
Dr Bakri Saeed Dr Andrew Skillen Dr Jolanta Weaver	Fasting homocysteine levels in adults with type 1 diabetes and retinopathy	2004
Dr Akheel Syed Dr Jolanta Weaver	Insulin resistance and coronary artery disease: Body mass index may have affected results	2004
Dr Akheel Syed Dr Jolanta Weaver	Insulin resistance and coronary artery disease: lean subjects should be used as controls	2004
Dr Salman Razvi Dr Elizabeth McIntyre Dr S Wahid Dr Jolanta Weaver	Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: The Gateshead protocol	2004
Dr Salman Razvi Dr Elizabeth McIntyre Dr Jolanta Weaver	Low failure rate of fixed dose 400 MBq131I with pre-treatment with Carbimazole for thyrotoxicosis; The Gateshead protocol	2004
Dr Akheel Syed Professor Julie Irving Dr Chris Redfern Dr Andrew Hall Professor Nigel Unwin et al.	Low Prevalence of the N363S Polymorphism of the Glucocorticoid Receptor in South Asians Living in the United Kingdom	2004
Dr Jolanta Weaver	Metabolic syndrome; a new disease	2004
Dr Jolanta Weaver	Metabolic Syndrome; new disease	2004
Dr Jolanta Weaver	Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84	2004
Dr Salman Razvi Dr Jolanta Weaver	Subclinical hypothyroidism and cardiovascular risk	2004
Dr Jolanta Weaver	Subclinical hypothyroidism and cardiovascular risk [1] (multiple letters)	2004
Dr Jolanta Weaver	The Prospective Pioglitazone Clinical Trial in Macrovascular Events (Proactive)	2004
Dr Jolanta Weaver Dr Salman Razvi	Withdrawal of anti-thyroid drugs (ATD) in a retrospective analysis of patients treated for Graves’s thyrotoxicosis.	2004
Dr Jolanta Weaver	Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL study	2003
Dr Jolanta Weaver	Losartan Reduces the Cost Associated with Diabetic End-stage Renal Disease	2003
Dr Bakri Saeed Dr Jolanta Weaver	Comparison of two direct methods for HDL-chlesterol measurement with an indirect precipitation method in diabetic patients	2002
Dr Jolanta Weaver	Influence of Growth Hormone on Accretion of Bone Mass	2002
Dr Jolanta Weaver	MicroAlbuminuria Reduction with Valsartan in patients with type 2 diabetes mellitus	2002
Javed Sultan Dr Bakri Saeed Dr Jolanta Weaver	Serum fructosamine is a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia	2002
Dr Bakri Saeed Dr Jolanta Weaver	Severe hyponatraemia: investigation and management in a district general hospital	2002
Dr Jolanta Weaver	Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course	2001
Dr Jolanta Weaver	The influence of gender on the short and long term effects of growth hormone replacement on bone metabolism and bone density in hypopituitary adults: 5 year study	2001
Dr Mark Dobson Dr Chris Redfern Professor Nigel Unwin Dr Jolanta Weaver	The N363S polymorphism of the glucocorticoid receptor: Potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus	2001
Professor Roy Taylor Dr Jolanta Weaver	Appropriate insulin regimes for type 2 diabetes: A multicenter randomized crossover study	2000
Professor Roy Taylor Dr Jolanta Weaver	Appropriate Insulin Regimes for Type 2 Diabetes: a multicenter randomized crossover study	2000
Dr Jolanta Weaver	The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)	2000